Teva Pharmaceuticals USA is voluntarily recalling approximately 87,342 bottles of Brinzolamide Ophthalmic Suspension, USP 1% (a generic eye medication) due to a defect in the dropper container. A piece of the cap notch can break off and block the nozzle, which may prevent the medicine from being dispensed correctly. The recall affects 10 ml and 15 ml dropper bottles with various lot numbers and expiration dates ranging from November 2022 to March 2023.
If the dropper nozzle is blocked, patients may be unable to dispense their medication, leading to missed doses and potential health complications like increased eye pressure. No injuries or incidents have been reported to date.
You have 2 options:
Rx Only
Rx Only
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.